Currently out of the existing stock ratings of Jason Mills, 22 are a HOLD (10.43%), 187 are a BUY (88.63%), 2 are a SELL (0.95%).
Analyst Jason Mills, currently employed at CANACCORD, has had 82.58% of price targets met with an average potential upside of 23.15%, reached in 321 days on average. Previously, Jason Mills worked at TD COWEN.
Jason Mills has documented 430 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on TMDX, TransMedics Group at 09-Nov-2026.
Analyst best performing recommendations are on ELGX (ENDOLOGIX).
The best stock recommendation documented was for VAPO (VAPOTHERM) on 6/5/2020. The price target of $272 was fulfilled within 5 days with a profit of $30.16 (12.47%), with a performance score of 24.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Dec-2013
$46
$1.66 (3.74%)
$56
17 days ago
(30-Oct-2026)
24/40 (60%)
$4.02 (9.58%)
329
Hold Since 05-Oct-2026
$44
$-0.34 (-0.77%)
$48
18 days ago
(29-Oct-2026)
25/35 (71.43%)
$1.31 (3.07%)
239
Buy Since 16-Jan-2026
$65
18 days ago
(29-Oct-2026)
0/4 (0%)
$21.28 (48.67%)
Hold Since 30-Jul-2026
$45
$0.66 (1.49%)
$48
18 days ago
(29-Oct-2026)
19/26 (73.08%)
$2.31 (5.41%)
187
Buy Since 16-Jun-2025
$50
$5.66 (12.76%)
$74
18 days ago
(29-Oct-2026)
0/7 (0%)
$7.31 (17.12%)
Which stock is Jason Mills most bullish on?
What Year was the first public recommendation made by Jason Mills?